Global Smart Insulin Pens Market Will Surpass USD 180.8 Billion at 11.9% CAGR Growth Says Vantage Market Research
Vantage Market Research, The North Star for the Working World
Vantage Market Research, The North Star for the Working World

WASHINGTON, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Smart Insulin Pens Market finds that the surge in the occurrence of diabetes worldwide is expediting market growth. In addition, the rising product launches and approval of Smart Insulin Pens Market and technological advancements are anticipated to augment the development of the Global Smart Insulin Pens Market during the forecast period. The Global Market revenue was valued at USD 92.1 Million in 2021.

The Global Smart Insulin Pens Market size is forecast to reach USD 180.8 Million by 2028 and is expected to grow to exhibit a Compound Annual Growth Rate (CAGR) of 11.9% during the forecast period; states Vantage Market Research, in a report, titled “Smart Insulin Pens Market Size, Share & Trends Analysis Report by End Users (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings), by Type (First Generation Pens, Second Generation Pens), by Usability (Prefilled, Reusable), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)”.

Get Access to a Free Copy of Our Latest Sample Report @ https://www.vantagemarketresearch.com/smart-insulin-pens-market-1830/request-sample

Key Industry Findings & Insights from the report:

  • The global Smart Insulin Pens Market was valued USD 92.1 Billion in 2021 and is all set to surpass USD 180.8 Billion by 2028, exhibiting a CAGR of 11.9% during the forecast period 2022-2028.

  • In terms of revenue, the application segment held the largest revenue share of in 2021 and is estimated to maintain its dominance for the forecast period.

  • In terms of revenue, the product segment held the second largest market share of in 2021 and is estimated to grow rapidly during the forecast period.

  • The growth can be attributed to rapid urbanization, technological advancement, an increase in investment by developing countries.

  • North America captured the lion share in 2021 and is projected to retain its position over the forecast period. This can be attributed to the existence of a significant number of Smart Insulin Pens industry companies and the high adoption rate owing to government measures that stimulate this industry in this region. The growth is primarily due to the increasing collaborations.

List of Prominent Players in Smart Insulin Pens Market:

  • Emperra GmbH

  • Jiangsu Deflu Medical Device Co. Ltd.

  • Medtronic PLC

  • Novo Nordisk

  • Pendiq

  • Sanofi

  • Berlin-Chemie

  • Bigfoot Biomedical

  • Digital Medics Pty Ltd.

  • Eli Lilly & Company